<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25640" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Meningococcal Disease (Neisseria meningitidis Infection) </title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Nguyen</surname>
            <given-names>Nixon</given-names>
          </name>
          <aff>WellStar Kennestone Regional Med. Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ashong</surname>
            <given-names>Derrick</given-names>
          </name>
          <aff>Wellstar Kennestone, Augusta University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Nixon Nguyen declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Derrick Ashong declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>27</day>
          <month>2</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25640.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Meningococcal&#x000a0;disease is an infection caused by the bacterium&#x000a0;<italic toggle="yes">Neisseria meningitidis</italic>.&#x000a0;Meningococcal infections affect individuals of all ages, including healthy&#x000a0;young adults. <italic toggle="yes">N meningitidis</italic><bold>&#x000a0;</bold>is the leading cause of bacterial meningitis in children and young adults, and the second-leading cause of community-acquired bacterial meningitis&#x000a0;in adults. Although meningitis and meningococcemia are the classical presentations of meningococcal disease, a broad spectrum of clinical manifestations exists, spanning&#x000a0;from asymptomatic nasopharyngeal colonization to fulminant disease. Prompt identification of patients with meningococcal disease,&#x000a0;initiation of treatment, and prophylaxis for their close contacts&#x000a0;are critical because meningococcal disease can rapidly progress and cause severe complications or death.</p>
        <p>This educational activity reviews the etiology and epidemiology of&#x000a0;<italic toggle="yes">N meningitidis </italic>infection. The need for a thorough history and clinical evaluation to develop&#x000a0;tailored&#x000a0;treatment strategies for patients with <italic toggle="yes">N meningitidis</italic>&#x000a0;infection. This course highlights the&#x000a0;need for&#x000a0;interprofessional team collaboration&#x000a0;to improve the management of meningococcal disease and patient outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify&#x000a0;the clinical manifestations of <italic toggle="yes">Neisseria meningitidis </italic>infection.</p></list-item><list-item><p>Apply evidence-based diagnostic strategies&#x000a0;for patients suspected&#x000a0;of having&#x000a0;<italic toggle="yes">Neisseria meningitidis</italic> infection.&#x000a0;</p></list-item><list-item><p>Implement timely and appropriate&#x000a0;treatment strategies for patients with&#x000a0;<italic toggle="yes">Neisseria meningitidis</italic> infection.</p></list-item><list-item><p>Collaborate with interprofessional team&#x000a0;members to improve the care coordination of those with&#x000a0;<italic toggle="yes">Neisseria meningitidis</italic> infection, improving patient outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25640&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25640">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25640.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p><italic toggle="yes">Neisseria&#x000a0;<italic toggle="yes">meningitidis</italic></italic>&#x000a0;was first discovered by Anton Weichselbaum<bold>&#x000a0;</bold>in 1887<bold>&#x000a0;</bold>during his analysis of the cerebrospinal fluid (CSF)&#x000a0;from a patient infected with meningitis.<xref ref-type="bibr" rid="article-25640.r1">[1]</xref>&#x000a0;<italic toggle="yes">N meningitidis</italic> is a human-specific bacterium that causes a multitude of illnesses, collectively termed as meningococcal disease. Up to 10% of the general population carries the bacteria in their nose and throat without experiencing any adverse effects.&#x000a0;Risk factors for meningococcal carriage include being in the&#x000a0;adolescent and young adult age group, being male, living in congregate conditions, being exposed to cigarette smoke, and frequently&#x000a0;attending bars and parties.<xref ref-type="bibr" rid="article-25640.r2">[2]</xref>&#x000a0;</p>
        <p><italic toggle="yes">N&#x000a0;<italic toggle="yes">meningitidis</italic></italic>&#x000a0;is associated with many infections. However, its association with fulminant meningococcemia and meningococcal meningitis has led to its significant impact. More importantly, despite recent vaccine campaigns to help reduce complications of this disease, its effects continue to impact at-risk populations.<xref ref-type="bibr" rid="article-25640.r3">[3]</xref></p>
      </sec>
      <sec id="article-25640.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p><italic toggle="yes">N meningitidis</italic> is an aerobic or facultative anaerobic, gram-negative diplococcus that exclusively infects humans (see <bold>Image.</bold> Diplococci).<xref ref-type="bibr" rid="article-25640.r4">[4]</xref>&#x000a0;There are at least 12 serotypes based on unique capsular polysaccharides of <italic toggle="yes">N meningitidis</italic>, with serotypes A, B, C, W, X, and Y responsible for&#x000a0;the majority of meningococcal infections. Serotypes A and C are the main serotypes responsible for meningococcal disease in Africa. Serotypes B, C, and Y are the main serotypes causing disease in Europe, the United States, and Canada.<xref ref-type="bibr" rid="article-25640.r5">[5]</xref> Serotype W is responsible for epidemic outbreaks&#x000a0;worldwide and is associated&#x000a0;with the Hajj pilgrimages&#x000a0;to Saudi Arabia.<xref ref-type="bibr" rid="article-25640.r6">[6]</xref></p>
        <p><italic toggle="yes">N meningitidis</italic>&#x000a0;is a common and significant cause of community-acquired bacterial meningitis in the United States,&#x000a0;affecting children and adults. It is a devastating infection with a high mortality rate&#x000a0;and is the second most common cause of community-acquired adult bacterial meningitis after <italic toggle="yes">Streptococcus&#x000a0;pneumoniae</italic>.<xref ref-type="bibr" rid="article-25640.r7">[7]</xref><italic toggle="yes"><bold>&#x000a0;</bold></italic>Other infections that&#x000a0;<italic toggle="yes">N meningitidis</italic>&#x000a0;can cause are meningococcemia (a bloodstream infection&#x000a0;caused by the bacterium), pneumonia, septic arthritis, pericarditis, and urethritis. In addition,&#x000a0;<italic toggle="yes">N meningitidis</italic> can also cause endemic and epidemic infections, affecting young, healthy adults.<xref ref-type="bibr" rid="article-25640.r5">[5]</xref></p>
      </sec>
      <sec id="article-25640.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The incidence of meningococcal disease has decreased<bold>&#x000a0;</bold>with the routine administration of meningococcal vaccination.&#x000a0;In the United States, the&#x000a0;incidence of meningococcal disease decreased&#x000a0;from 1.2 cases per 100,000 individuals in 1996 to 0.1 cases per 100,000 individuals in 2018.<xref ref-type="bibr" rid="article-25640.r5">[5]</xref> The highest incidence of meningococcal disease appears in infants younger than 1 (2.45 cases per 100,000 individuals).<xref ref-type="bibr" rid="article-25640.r8">[8]</xref>&#x000a0;<italic toggle="yes">N meningitidis</italic> can cause endemic and epidemic outbreaks&#x000a0;and is a significant cause of bacterial meningitis in sub-Saharan Africa, leading to the region being&#x000a0;called the<bold>&#x000a0;</bold>meningitis belt.<xref ref-type="bibr" rid="article-25640.r5">[5]</xref>&#x000a0;The mortality rate&#x000a0;varies from approximately 10%&#x000a0;to 14% among patients who receive treatment and can reach up to 50% among patients who do not receive treatment.<xref ref-type="bibr" rid="article-25640.r9">[9]</xref></p>
      </sec>
      <sec id="article-25640.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Humans are the exclusive hosts of <italic toggle="yes">Neisseria meningitidis</italic>, carrying the pathogen in their nasopharynx before the onset of systemic infection.&#x000a0;Colonized humans may be asymptomatic carriers.<xref ref-type="bibr" rid="article-25640.r2">[2]</xref>&#x000a0;Colonization of the nasopharynx&#x000a0;puts individuals who are in close contact with infected patients, such as family members, college roommates, and military recruits, at an increased risk of contracting&#x000a0;<italic toggle="yes">N meningitidis </italic>and possible infection. Individuals&#x000a0;involved in laboratory work or medical care exposure, such as intubating an infected patient with no face shield or mask, are also at an increased risk of&#x000a0;<italic toggle="yes">N meningitidis</italic> colonization of the nasopharynx through inhaling aerosolized particles containing the bacteria. The incubation period varies and ranges from 1 to 14 days.<xref ref-type="bibr" rid="article-25640.r10">[10]</xref></p>
        <p>Once <italic toggle="yes">N meningitidis</italic> is colonized, several virulence factors help the bacterium in invading human cells and the immune system. After<italic toggle="yes"><italic toggle="yes">&#x000a0;</italic></italic>it<italic toggle="yes"><italic toggle="yes">&#x000a0;</italic></italic>invades the bloodstream, a robust immune response is triggered, leading to&#x000a0;endothelial damage, capillary leakage, tissue necrosis, organ failure, and the development of meningococcal sepsis. Bloodstream invasion is considered to be the primary route&#x000a0;to the brain, but <italic toggle="yes">N meningitidis&#x000a0;</italic>can also cross the cribriform plate of the ethmoid bone.<xref ref-type="bibr" rid="article-25640.r11">[11]</xref></p>
        <p>Similar to&#x000a0;many other diseases,&#x000a0;the immune system is essential in protecting the host. Certain health conditions that weaken the human immune system increase the risk of contracting meningococcal diseases, including meningococcemia and meningitis. These conditions&#x000a0;include HIV infection, AIDS, asplenia, and complement deficiency.<xref ref-type="bibr" rid="article-25640.r4">[4]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-25640.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The clinical presentation of<italic toggle="yes"> N&#x000a0;<italic toggle="yes">meningitidis</italic>&#x000a0;</italic>can vary widely and may initially appear benign, making it difficult to diagnose, especially in areas with no reported epidemics. Typically, the initial presentation of <italic toggle="yes">N&#x000a0;<italic toggle="yes"><italic toggle="yes">meningitidis</italic></italic>
</italic>caused by meningitis can include sudden onset of fever, headache, nausea, vomiting, severe myalgias, nonspecific rash, sore throat, and other upper respiratory symptoms. These symptoms&#x000a0;may be confused with a multitude of other illnesses. The potential for rapid disease progression, especially given the possibility of death within hours of symptom onset, makes early identification of meningococcal disease challenging due to its low incidence and nonspecific early symptoms. Later presentation of the meningococcal disease includes neck stiffness, photophobia, petechiae or hemorrhagic rash, altered mental status, shock, abnormal skin color, purpura fulminans, or even disseminated intravascular coagulation.<xref ref-type="bibr" rid="article-25640.r10">[10]</xref></p>
        <p>Vital signs may include hypotension and tachycardia, which indicate early signs of sepsis. A complete physical examination should be conducted, including a thorough skin inspection for any signs of a&#x000a0;rash. The rash, a distinguishing feature, may initially appear as small lesions that may appear urticarial, macular, or papular. The rash can develop into petechiae, purpura,&#x000a0;or ecchymosis later (see <bold>Image.</bold> Petechiae). These may be early signs of thrombocytopenia, purpura fulminans, and disseminated intravascular coagulation.<xref ref-type="bibr" rid="article-25640.r10">[10]</xref> Although Kernig and Brudzinski signs are classic signs of meningitis, their respective sensitivities of 55.5% and 53.3% make them unreliable in excluding meningitis.<xref ref-type="bibr" rid="article-25640.r12">[12]</xref>&#x000a0;When considering signs and symptoms of the disease, it is important to note that the classic triad of fever, altered mental status, and nuchal rigidity is rare, occurring in only about 44% of cases. However, when 2 of the 4 symptoms, including headache, altered mental status, neck stiffness, and fever, were present, 95% of patients ultimately diagnosed with meningitis were identified.<xref ref-type="bibr" rid="article-25640.r13">[13]</xref>&#x000a0;Clinicians should consider <italic toggle="yes">N&#x000a0;<italic toggle="yes"><italic toggle="yes"><italic toggle="yes">meningitidis</italic></italic></italic></italic>&#x000a0;infection in patients with sudden onset of fever who display early signs of sepsis, rapidly progressing disease, and rash.</p>
        <p>Purpura fulminans, a complication of meningococcal disease resulting from&#x000a0;vascular collapse, is characterized by cutaneous hemorrhage and skin necrosis due to vascular thrombosis and disseminated intravascular coagulation.&#x000a0;Typically, petechiae and erythema are&#x000a0;observed on the skin but can progress to ecchymosis and eventually painful areas of necrosis, with the development of bullae and vesicles. Gangrenous necrosis can occur and be severe, often requiring limb amputation. Atypical skin color, cold hands and feet, and painful legs may be the signs of vascular compromise.<xref ref-type="bibr" rid="article-25640.r10">[10]</xref></p>
        <p>Although these infections are rarely&#x000a0;caused by&#x000a0;<italic toggle="yes">N&#x000a0;<italic toggle="yes"><italic toggle="yes"><italic toggle="yes">meningitidis</italic></italic></italic></italic>, meningococcal disease&#x000a0;can also include&#x000a0;pneumonia, septic arthritis, urethritis, and pericarditis.<xref ref-type="bibr" rid="article-25640.r5">[5]</xref></p>
      </sec>
      <sec id="article-25640.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>A lumbar puncture is the preferred diagnostic tool for identifying meningitis. Prioritizing a lumbar puncture ensures prompt evaluation and diagnosis.&#x000a0;Evidence of elevated intracranial pressure,&#x000a0;such as&#x000a0;altered mental status, new-onset seizure within&#x000a0;1 week of symptoms, papilledema, an immunocompromised state, or focal neurologic deficits; coagulopathy; and cardiorespiratory insufficiency are contraindications to lumbar puncture. Antibiotic administration should occur promptly, even before lumbar puncture completion, for those patients when meningitis is highly likely to be&#x000a0;the diagnosis.<xref ref-type="bibr" rid="article-25640.r9">[9]</xref> Even in pretreated patients, blood cultures and CSF studies can still be useful. CSF analysis should include gram staining, culture, glucose, cell count, and protein count. CSF findings that suggest bacterial meningitis include decreased<bold>&#x000a0;</bold>glucose levels, polymorphonuclear pleocytosis, and increased protein levels. CSF culture is the gold standard for the diagnosis of bacterial meningitis.<xref ref-type="bibr" rid="article-25640.r14">[14]</xref></p>
        <p>CSF gram staining,&#x000a0;polymerase chain reaction (PCR), and latex agglutination may aid in confirmation, particularly in patients with negative CSF cultures after antibiotic pretreatment. PCR detects strands of bacterial DNA, not requiring an intact bacterium for detection, whereas latex agglutination detects capsular antigens.<xref ref-type="bibr" rid="article-25640.r14">[14]</xref></p>
        <p>Computed tomography (CT) imaging may assist in the diagnosis of patients with altered mental status, mainly to rule out other diagnoses under consideration.<xref ref-type="bibr" rid="article-25640.r9">[9]</xref>&#x000a0;If imaging is necessary, it is crucial to coordinate with the nursing team and imaging suite to avoid delaying antibiotic administration.</p>
      </sec>
      <sec id="article-25640.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Early recognition and treatment of meningococcal infections are imperative in improving outcomes. The primary focus in treating meningococcal infection includes administering&#x000a0;antibiotics, implementing isolation, contact precaution, consulting with infectious disease specialists, management in the intensive care unit (ICU), management of coagulopathies, and identifying individuals at risk who may have been exposed to <italic toggle="yes">N meningitidis</italic>.<xref ref-type="bibr" rid="article-25640.r9">[9]</xref></p>
        <p>Because meningococcal meningitis can present similarly to other bacterial meningitides, empiric treatment should be&#x000a0;initiated while awaiting culture results. This preemptive approach includes a third-generation cephalosporin such as ceftriaxone or cefotaxime. If culture identifies the organism as penicillin-susceptible, treatment can be switched to penicillin G. However, continuing third-generation cephalosporin treatment is also an option. For patients who have significant allergies to penicillin and other beta-lactams, chloramphenicol may be an alternative. The duration of antibiotic therapy is&#x000a0;typically&#x000a0;5&#x000a0;to&#x000a0;6 days.<xref ref-type="bibr" rid="article-25640.r9">[9]</xref><xref ref-type="bibr" rid="article-25640.r15">[15]</xref></p>
        <p>
<bold>Dosages</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Ceftriaxone&#x000a0;dosing is 2 g for adults and 50 mg/kg&#x000a0;for pediatric patients older than 1 month given intravenously (IV) every 12 hours, whereas&#x000a0;cefotaxime dosing is 2 g every 4&#x000a0;to 6 hours for adults&#x000a0;and 50 mg/kg&#x000a0;for pediatric patients older than 1 month every 6 hours.<xref ref-type="bibr" rid="article-25640.r9">[9]</xref>
<list list-type="bullet"><list-item><p>Third-generation cephalosporins are generally preferable due to their high efficacy and simpler&#x000a0;dosing regimens.</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Penicillin G dosing is 4 million units every 4 hours IV&#x000a0;for&#x000a0;adults and pediatric patients older than 1 month.<xref ref-type="bibr" rid="article-25640.r9">[9]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Chloramphenicol dosing is 50 mg/kg IV 4 times per day.<xref ref-type="bibr" rid="article-25640.r9">[9]</xref>
<list list-type="bullet"><list-item><p>Serum concentrations require monitoring because of the risk of chloramphenicol toxicity.<xref ref-type="bibr" rid="article-25640.r16">[16]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>High-dose dexamethasone should be administered at initial suspicion of bacterial meningitis due to its protective benefits in pneumococcal meningitis.<xref ref-type="bibr" rid="article-25640.r9">[9]</xref><xref ref-type="bibr" rid="article-25640.r17">[17]</xref>&#x000a0;Dexamethasone should be administered IV within 4 hours before but no more than 12 hours after the first dose of IV antibiotics. The dosage should be 0.15 mg/kg every 6 hours up to a maximum dosage of 10 mg every 6 hours.<xref ref-type="bibr" rid="article-25640.r9">[9]</xref><xref ref-type="bibr" rid="article-25640.r15">[15]</xref>&#x000a0;However, dexamethasone has no therapeutic benefit in meningococcal meningitis and should be discontinued once this diagnosis is established.<xref ref-type="bibr" rid="article-25640.r17">[17]</xref><xref ref-type="bibr" rid="article-25640.r15">[15]</xref></p>
          </list-item>
        </list>
        <p>Patients with meningococcal infection should also be treated aggressively with supportive care, especially for sepsis or septic shock. This may include intravenous fluid resuscitation and the use of vasopressors such as norepinephrine.<xref ref-type="bibr" rid="article-25640.r15">[15]</xref> Patients who show evidence of disseminated intravascular coagulation may require aggressive hydration, blood transfusions, platelet replacement, and possibly even coagulation factor replacement. Researchers have proposed protein C as an adjuvant treatment, but its use is controversial and currently not commonly used.<xref ref-type="bibr" rid="article-25640.r9">[9]</xref></p>
      </sec>
      <sec id="article-25640.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p><italic toggle="yes">S pneumoniae</italic> is the most common cause of bacterial meningitis in the United States and should be included in the differential diagnosis for patients suspected of having meningococcal meningitis. Less common causes of bacterial meningitis include&#x000a0;<italic toggle="yes">Haemophilus influenzae</italic>,&#x000a0;group B <italic toggle="yes">Streptococcus</italic>, and&#x000a0;<italic toggle="yes">Listeria monocytogenes</italic>.<xref ref-type="bibr" rid="article-25640.r14">[14]</xref>&#x000a0;Other causes of meningitis include viral, tuberculous, eosinophilic, and fungal meningitis and noninfectious causes such as malignancy.<xref ref-type="bibr" rid="article-25640.r18">[18]</xref></p>
        <p>Clinicians examining adults with a maculopapular rash and fever should consider alternate etiologies, including&#x000a0;infectious mononucleosis, West Nile virus, Zika virus, HIV, Ebola virus, Rocky Mountain spotted fever, ehrlichiosis, and hypersensitivity drug reactions.<xref ref-type="bibr" rid="article-25640.r19">[19]</xref>&#x000a0;In addition, children with a maculopapular rash and fever should be considered for a differential diagnosis that includes Kawasaki disease, measles, scarlet fever, rubella, parvovirus B19, roseola,&#x000a0;Epstein-Barr virus, and hand, foot, and mouth disease.<xref ref-type="bibr" rid="article-25640.r20">[20]</xref></p>
      </sec>
      <sec id="article-25640.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Although&#x000a0;the mortality rate of meningococcal infection can be as high as 50% in untreated patients, early and aggressive treatment can reduce the mortality rate to approximately 10%&#x000a0;to 14%. Early administration of antibiotics is&#x000a0;crucial&#x000a0;in determining a good outcome of meningococcal infection. Even with treatment, long-term complications can still occur in 11%&#x000a0;to 19% of survivors.<xref ref-type="bibr" rid="article-25640.r9">[9]</xref></p>
        <p>Similar to other causes of bacterial meningitis, patients who survive meningococcal infections should undergo routine follow-up. Hearing tests are recommended within&#x000a0;4 weeks of hospital discharge.&#x000a0;Orthopedic follow-up and prosthetic fitting are necessary for patients who have suffered limb amputations. Patients may experience psychological and psychiatric complications, including posttraumatic stress disorder, depression, and behavioral abnormalities, requiring follow-up with psychologists&#x000a0;and psychiatrists.<xref ref-type="bibr" rid="article-25640.r15">[15]</xref></p>
      </sec>
      <sec id="article-25640.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Common complications of meningococcal disease include chronic pain, skin scarring, limb amputation, and neurological impairments,&#x000a0;ranging from hearing and visual impairments to motor function impairments. Hearing impairment and amputations occur in approximately 3% of cases, arthritis occurs in 10% of cases, and postinfection inflammatory syndrome occurs in 6% to 15% of cases. Up to one-third of survivors of meningococcal disease experience psychological disorders such as posttraumatic stress disorder, anxiety, and depression.<xref ref-type="bibr" rid="article-25640.r9">[9]</xref>&#x000a0;Urgent complications of meningococcal disease include septic shock,&#x000a0;purpura fulminans,&#x000a0;seizures,&#x000a0;hydrocephalus, cerebral venous sinus thrombosis, and subdural empyema.<xref ref-type="bibr" rid="article-25640.r15">[15]</xref></p>
      </sec>
      <sec id="article-25640.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>The interprofessional team managing meningococcal infection consists of internists, pediatricians, infectious disease specialists, hematologists, neurologists, and nursing staff.<xref ref-type="bibr" rid="article-25640.r15">[15]</xref></p>
      </sec>
      <sec id="article-25640.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Early recognition and treatment of those infected are crucial, as meningococcal infection is a devastating infectious disease that has led to&#x000a0;epidemics in the past and can do so again. Any meningococcal infection is reportable, and local health departments should be notified.<xref ref-type="bibr" rid="article-25640.r5">[5]</xref></p>
        <p>Vaccination&#x000a0;is the best strategy for preventing meningococcal disease, especially in populations at higher risk. The infectious disease nurse should educate patients about vaccination. Vaccines against&#x000a0;<italic toggle="yes">N meningitidis</italic> serogroups A, C, W, Y, and B are routinely recommended in the United States for adolescents, young adults, and&#x000a0;individuals at increased risk for meningococcal disease. The overall burden of meningococcal infection worldwide has diminished due to these vaccinations.<xref ref-type="bibr" rid="article-25640.r5">[5]</xref></p>
        <p>Individuals at risk, including college students, military recruits, immunocompromised patients such as those with HIV/AIDS, complement deficiency, and those with asplenia, should be vaccinated. Individuals&#x000a0;who work with <italic toggle="yes">N meningitidis </italic>in laboratories, travelers to endemic areas such as the meningitis belt, and those&#x000a0;exposed to outbreaks of meningococcal vaccine should also be vaccinated based on local epidemiology.<xref ref-type="bibr" rid="article-25640.r5">[5]</xref></p>
        <table-wrap id="article-25640.table0" position="float" orientation="portrait">
          <caption>
            <title>Table. Routine meningococcal vaccine recommendations for healthy adolescents and young adults aged 11&#x000a0;through 23 in the United States&#x000a0;[5]</title>
          </caption>
          <table style="width: 800px;" border="1" cellspacing="1" cellpadding="2">
            <tbody>
              <tr style="height: 13px;">
                <td style="width: 146px; height: 13px;" rowspan="1" colspan="1">
<bold>Meningococcal Vaccine</bold>
</td>
                <td style="width: 460.906px; height: 13px;" rowspan="1" colspan="1">
<bold>Primary Dosage(s)</bold>
</td>
                <td style="width: 878.094px; height: 13px;" rowspan="1" colspan="1">
<bold>Booster Dosage(s)</bold>
</td>
              </tr>
              <tr style="height: 1.27084px;">
                <td style="width: 146px; height: 1.27084px;" rowspan="1" colspan="1">MenACWY(for ages 11-21)*</td>
                <td style="width: 460.906px; height: 1.27084px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>1 dose at age 11 or 12&#x000a0;</p></list-item></list>
<list list-type="bullet"><list-item><p>Catch-up vaccination&#x000a0;at ages 13-18 for adolescents who did not receive the primary dose at the recommended age</p></list-item></list>
</td>
                <td style="width: 878.094px; height: 1.27084px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>1 dose at age &#x02265;16; the minimum interval between doses is 8 weeks.</p></list-item></list>
<list list-type="bullet"><list-item><p>If the first dose was given after the age of 16, a booster is not needed unless the individual is at higher risk for meningococcal disease.</p></list-item></list>
<list list-type="bullet"><list-item><p>College students living in residence halls should receive &#x02265;1 dose of MenACWY &#x02264;5 years before college entry.</p></list-item></list>
</td>
              </tr>
              <tr style="height: 86px;">
                <td style="width: 146px; height: 86px;" rowspan="1" colspan="1">MenB(for ages 16-23)</td>
                <td style="width: 460.906px; height: 86px;" rowspan="1" colspan="1">
<p>Preferred age: 16-18&#x000a0;</p>
<list list-type="bullet"><list-item><p>Either:
<list list-type="bullet"><list-item><p>MenB-4C: 2 doses, &#x02265;1 month apart, or</p></list-item><list-item><p>MenB-FHbp: 2 doses, &#x02265;6 months apart</p></list-item></list>
</p></list-item></list>
</td>
                <td style="width: 878.094px; height: 86px;" rowspan="1" colspan="1">
<p>Not routinely recommended unless the individual becomes at risk.</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>*Although the Advisory Committee on Immunization Practices (ACIP) recommends routine MenACWY vaccination only for individuals aged 11 through 18, MenACWY may be given to individuals aged 19 through 21 if they have not been vaccinated previously.</p>
        <p>Moreover, the MenACWY vaccine is mandatory for all individuals visiting Mecca for Hajj/Umrah.<xref ref-type="bibr" rid="article-25640.r5">[5]</xref></p>
      </sec>
      <sec id="article-25640.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Individuals who come into close contact with meningococcal-infected patients can themselves become infected and display symptoms within&#x000a0;14 days after initial contact. Close contact refers to proximity&#x000a0;with the patient for more than&#x000a0;4 hours within the past 7 days. Examples&#x000a0;of close contacts include family members, roommates, military recruits, and individuals in daycare centers.<xref ref-type="bibr" rid="article-25640.r10">[10]</xref> Individuals&#x000a0;who are exposed to the patient's oral secretions, such as through kissing, or respiratory secretions, such as during intubation, suctioning, and&#x000a0;proximity with&#x000a0;passengers on a long flight, are also at risk. If recognized, antimicrobial chemoprophylaxis should be initiated. Due to its high efficacy, chemoprophylaxis should be strongly considered&#x000a0;for patients who may have had questionable close contact with an infected patient.</p>
        <p>Several antimicrobial chemoprophylaxis options are listed below.<xref ref-type="bibr" rid="article-25640.r9">[9]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Ceftriaxone&#x000a0;is administered at 250 mg intramuscularly as a one-time dose for adults and 125 mg for pediatric patients younger than 15.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Rifampin is prescribed at 600 mg orally or intravenously twice daily for 2 days for adults. In pediatric patients younger than 1 month, the recommended dosage is 5 mg/kg, whereas for those older than 1 month, it is 10 mg/kg. Rifampin is not recommended for pregnant patients.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Ciprofloxacin is given orally at 500 mg as a one-time dose for adults, and for pediatric patients older than 1 month, the dosage is 20 mg/kg (maximum 500 mg).</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Azithromycin,&#x000a0;typically reserved as a last choice, is administered orally at 500 mg as a one-time dose in adults&#x000a0;and 10 mg/kg (maximum 500 mg) in pediatric patients older than 1 month.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25640.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Meningococcal infection is a devastating, contagious disease that can progress rapidly. Recognizing the illness is perhaps the most challenging part of assessing and treating patients. This requires an interprofessional team consisting of physicians, infectious disease specialists, ICU nurses, pharmacists, adherence to proper isolation protocols, and collaboration with the local health department to treat infected patients. Meningococcal disease is reportable, and the local health department can assist in identifying individuals at risk and managing&#x000a0;outbreaks.<xref ref-type="bibr" rid="article-25640.r5">[5]</xref></p>
        <p>Clinicians who initiate treatment would benefit by enlisting the assistance of an infectious disease board-certified pharmacist. They can verify agent selection with the latest antibiogram data,&#x000a0;confirm dosage, and check for drug interactions that may compromise therapy. Nurses typically administer these agents and should have a comprehensive understanding of appropriate isolation protocols. They also monitor for therapeutic effectiveness and watch for any adverse reactions,&#x000a0;promptly notifying the healthcare team of any issues. The interprofessional team approach is the best way to optimize therapeutic results while minimizing the spread of infection and adverse reactions.</p>
      </sec>
      <sec id="article-25640.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25640&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25640">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/meningococcal-disease-neisseria-meningitidis-infection/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25640">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25640/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25640">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-25640.s17">
        <fig id="article-25640.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Petechiae. Close-up image showing petechiae scattered over the legs. Contributed by Rian Kabir, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Kabir_Petechiae_Updated" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-25640.s18">
        <title>References</title>
        <ref id="article-25640.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rouphael</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Stephens</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Neisseria meningitidis: biology, microbiology, and epidemiology.</article-title>
            <source>Methods Mol Biol</source>
            <year>2012</year>
            <volume>799</volume>
            <fpage>1</fpage>
            <page-range>1-20</page-range>
            <pub-id pub-id-type="pmid">21993636</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25640.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Santos-Neto</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Ferreira</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Feitosa</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Martinez-Silveira</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Campos</surname>
                <given-names>LC</given-names>
              </name>
            </person-group>
            <article-title>Carriage prevalence of Neisseria meningitidis in the Americas in the 21st century: a systematic review.</article-title>
            <source>Braz J Infect Dis</source>
            <year>2019</year>
            <season>Jul-Aug</season>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>254</fpage>
            <page-range>254-267</page-range>
            <pub-id pub-id-type="pmid">31344352</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25640.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Read</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Neisseria meningitidis and meningococcal disease: recent discoveries and innovations.</article-title>
            <source>Curr Opin Infect Dis</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>32</volume>
            <issue>6</issue>
            <fpage>601</fpage>
            <page-range>601-608</page-range>
            <pub-id pub-id-type="pmid">31567569</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25640.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takada</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fujiwara</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Inoue</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kataoka</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hadano</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Matsumoto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Morino</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shimizu</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Meningococcemia in Adults: A Review of the Literature.</article-title>
            <source>Intern Med</source>
            <year>2016</year>
            <volume>55</volume>
            <issue>6</issue>
            <fpage>567</fpage>
            <page-range>567-72</page-range>
            <pub-id pub-id-type="pmid">26984070</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25640.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mbaeyi</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Bozio</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Duffy</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rubin</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Hariri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stephens</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>MacNeil</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020.</article-title>
            <source>MMWR Recomm Rep</source>
            <year>2020</year>
            <month>Sep</month>
            <day>25</day>
            <volume>69</volume>
            <issue>9</issue>
            <fpage>1</fpage>
            <page-range>1-41</page-range>
            <pub-id pub-id-type="pmid">33417592</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25640.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Badur</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khalaf</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>&#x000d6;zt&#x000fc;rk</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Al-Raddadi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Amir</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Farahat</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Shibl</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Meningococcal Disease and Immunization Activities in Hajj and Umrah Pilgrimage: a review.</article-title>
            <source>Infect Dis Ther</source>
            <year>2022</year>
            <month>Aug</month>
            <volume>11</volume>
            <issue>4</issue>
            <fpage>1343</fpage>
            <page-range>1343-1369</page-range>
            <pub-id pub-id-type="pmid">35585384</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25640.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hasbun</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Progress and Challenges in Bacterial Meningitis: A Review.</article-title>
            <source>JAMA</source>
            <year>2022</year>
            <month>Dec</month>
            <day>06</day>
            <volume>328</volume>
            <issue>21</issue>
            <fpage>2147</fpage>
            <page-range>2147-2154</page-range>
            <pub-id pub-id-type="pmid">36472590</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25640.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>MacNeil</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Blain</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Cohn</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Current Epidemiology and Trends in Meningococcal Disease-United States, 1996-2015.</article-title>
            <source>Clin Infect Dis</source>
            <year>2018</year>
            <month>Apr</month>
            <day>03</day>
            <volume>66</volume>
            <issue>8</issue>
            <fpage>1276</fpage>
            <page-range>1276-1281</page-range>
            <pub-id pub-id-type="pmid">29126310</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25640.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nadel</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Treatment of Meningococcal Disease.</article-title>
            <source>J Adolesc Health</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>59</volume>
            <issue>2 Suppl</issue>
            <fpage>S21</fpage>
            <page-range>S21-8</page-range>
            <pub-id pub-id-type="pmid">27449146</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25640.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bosis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mayer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Esposito</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Meningococcal disease in childhood: epidemiology, clinical features and prevention.</article-title>
            <source>J Prev Med Hyg</source>
            <year>2015</year>
            <month>Aug</month>
            <day>31</day>
            <volume>56</volume>
            <issue>3</issue>
            <fpage>E121</fpage>
            <page-range>E121-4</page-range>
            <pub-id pub-id-type="pmid">26788732</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25640.r11">
          <label>11</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Siddiqui</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Ameer</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Gulick</surname>
                <given-names>PG</given-names>
              </name>
            </person-group>
            <chapter-title>Meningococcemia</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>28</day>
            <pub-id pub-id-type="pmid">30521270</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25640.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ala</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rahmani</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Abdollahi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Parsian</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Accuracy of Neck stiffness, Kernig, Brudzinski, and Jolt Accentuation of Headache Signs in Early Detection of Meningitis.</article-title>
            <source>Emerg (Tehran)</source>
            <year>2018</year>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>e8</fpage>
            <pub-id pub-id-type="pmid">29503833</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25640.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van de Beek</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>de Gans</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Spanjaard</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Weisfelt</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Reitsma</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Vermeulen</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Clinical features and prognostic factors in adults with bacterial meningitis.</article-title>
            <source>N Engl J Med</source>
            <year>2004</year>
            <month>Oct</month>
            <day>28</day>
            <volume>351</volume>
            <issue>18</issue>
            <fpage>1849</fpage>
            <page-range>1849-59</page-range>
            <pub-id pub-id-type="pmid">15509818</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25640.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brouwer</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Tunkel</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>van de Beek</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>23</volume>
            <issue>3</issue>
            <fpage>467</fpage>
            <page-range>467-92</page-range>
            <pub-id pub-id-type="pmid">20610819</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25640.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McGill</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Heyderman</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Michael</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Defres</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Beeching</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Borrow</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Glennie</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gaillemin</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Wyncoll</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kaczmarski</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nadel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thwaites</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>NW</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rhodes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Read</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Solomon</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults.</article-title>
            <source>J Infect</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>72</volume>
            <issue>4</issue>
            <fpage>405</fpage>
            <page-range>405-38</page-range>
            <pub-id pub-id-type="pmid">26845731</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25640.r16">
          <label>16</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Oong</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Tadi</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <chapter-title>Chloramphenicol</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>3</day>
            <pub-id pub-id-type="pmid">32310426</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25640.r17">
          <label>17</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Runde</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Anjum</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hafner</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <chapter-title>Bacterial Meningitis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>8</day>
            <pub-id pub-id-type="pmid">29261975</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25640.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Young</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Meningitis in adults: diagnosis and management.</article-title>
            <source>Intern Med J</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>48</volume>
            <issue>11</issue>
            <fpage>1294</fpage>
            <page-range>1294-1307</page-range>
            <pub-id pub-id-type="pmid">30387309</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25640.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muzumdar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rothe</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Grant-Kels</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>The rash with maculopapules and fever in adults.</article-title>
            <source>Clin Dermatol</source>
            <year>2019</year>
            <season>Mar-Apr</season>
            <volume>37</volume>
            <issue>2</issue>
            <fpage>109</fpage>
            <page-range>109-118</page-range>
            <pub-id pub-id-type="pmid">30981291</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25640.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muzumdar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rothe</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Grant-Kels</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>The rash with maculopapules and fever in children.</article-title>
            <source>Clin Dermatol</source>
            <year>2019</year>
            <season>Mar-Apr</season>
            <volume>37</volume>
            <issue>2</issue>
            <fpage>119</fpage>
            <page-range>119-128</page-range>
            <pub-id pub-id-type="pmid">30981292</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
